出典:Wikipedia
出典:『Wikipedia』 (2011/03/30 18:49 UTC 版)
Sunepitron (CP-93,393) is a combined 5-HT1A receptor agonist and α2-adrenergic receptor antagonist. It was previously under development by Pfizer for the treatment of depression and anxiety. It made it to phase III clinical trials before being discontinued.